not vested
Swiss-listed drug industry supplier Lonza Group is expected to begin the secondary trading of its shares on the Singapore Exchange at 0100 GMT.
The closing price of its Swiss-listed shares on Thursday was 55.95 Swiss francs ($62.326).
Source: Reuters